1-8 of 8
Rohan Halder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic Stem Cell Transplant for High-Risk Transfusion Dependent Thalassemia [Tdt] - a Comparative Analysis of Flu/Bu/Cy/ATG Versus Flu/Thio/Treo Regimen

Rohan Halder, Reshmi Harikumar Pillai, Vinayak Hemant Gupta, Sujay Rainchwar, Karuna Jha, Tribikram Panda, Rayaz Ahmed, Narendra Agrawal, Reema Singh, Dinesh Bhurani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4961.
https://doi.org/10.1182/blood-2023-186817
Published: 2023
Journal Articles

A Retrospective Comparative Analysis of Intensive Vs. Non-Intensive Chemotherapy in Treatment Naïve Acute Myeloid Leukemia (AML) Patients in India

Mohd Rizwan Mohamad Anwar Shaikh, Bhumika Singh, Reema Singh, Rohan Halder, Karuna Jha, Tribikram Panda, Rayaz Ahmed, Narendra Agrawal, Dinesh Bhurani
Journal: Blood
Blood (2023) 142 (Supplement 1): 5842.
https://doi.org/10.1182/blood-2023-188838
Published: 2023
Journal Articles

Casting Hope, Defying Odds: Unveiling the Impact of Haplo-Identical Stem Cell Transplant in Myeloid Malignancies - a Tertiary Cancer Care Center Experience

Reema Singh, Sujay Rainchwar, Rohan Halder, Niharika Bhatia, Karuna Jha, Tribikram Panda, Rayaz Ahmed, Dinesh Bhurani, Narendra Agrawal
Journal: Blood
Blood (2023) 142 (Supplement 1): 6983.
https://doi.org/10.1182/blood-2023-181474
Published: 2023
Journal Articles

Risk and Response Adapted Approach for Treatment of Myeloma: Pushing Autologous Transplant Down the Hierarchy

Aakanksha Singh, Reema Singh, Rohan Halder, Karuna Jha, Tribikram Panda, Amir Khan Maroof, Niharika Bhatia, Rayaz Ahmed, Dinesh Bhurani, Narendra Agrawal
Journal: Blood
Blood (2023) 142 (Supplement 1): 3600.
https://doi.org/10.1182/blood-2023-186745
Published: 2023
Journal Articles

An Observational Prospective Study of Dasatinib 50mg Daily As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia Patients in Chronic Phase

Reema Singh, Rohan Halder, Jyotsna Kapoor, Megha Verma, Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani
Journal: Blood
Blood (2022) 140 (Supplement 1): 12197–12199.
https://doi.org/10.1182/blood-2022-158453
Published: 2022
Journal Articles

Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia

Reema Singh, Rohan Halder, Megha Verma, Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani
Journal: Blood
Blood (2022) 140 (Supplement 1): 11713–11715.
https://doi.org/10.1182/blood-2022-162124
Published: 2022
Journal Articles

Retrospective Study of Treatment Free Remission in Patients with Chronic Myeloid Leukaemia(CML) Treated at Tertiary Care Oncology Centre from India

Megha Verma, Rohan Halder, Reema Singh, Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani
Journal: Blood
Blood (2022) 140 (Supplement 1): 12222.
https://doi.org/10.1182/blood-2022-168574
Published: 2022
Journal Articles

Individualized AML Induction with Venetoclax Based Therapy in Unfit Treatment Naïve Patients Aged ≤ 60 Years: A Real World Perspective from India

Mohd Rizwan Mohamad Anwar Shaikh, Pallavi Mehta, Sumeet Prakash Mirgh, Rohan Halder, Narendra Agrawal, Vishvdeep Khushoo, Rayaz Ahmed, Bhaarat Folbs, Divya Pratihast, Nitin Bansal, Dinesh Bhurani
Journal: Blood
Blood (2021) 138 (Supplement 1): 4417.
https://doi.org/10.1182/blood-2021-150435
Published: 2021